Thaçi, Diamant, April Armstrong, Kenneth B Gordon, Andrew Blauvelt, Carl Paul, Wolf-Henning Boehncke, Maggie Wang, Balint Szilagyi, Bengt Hoepken, Jeremy Lambert, and Mark Lebwohl. “Bimekizumab 3-Year Maintenance of Response in Week 16 Responders With Moderate to Severe Plaque Psoriasis: Results from Five Phase 3/3b Trials”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s306. Accessed July 19, 2024. https://jofskin.org/index.php/skin/article/view/2452.